NASDAQ:OMIC Singular Genomics Systems (OMIC) Stock Price, News & Analysis $20.01 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Singular Genomics Systems Stock (NASDAQ:OMIC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OMIC alerts:Sign Up Key Stats Today's Range$20.01▼$20.0150-Day Range$20.01▼$20.0152-Week Range$5.34▼$23.41VolumeN/AAverage Volume41,211 shsMarket Capitalization$50.83 millionP/E RatioN/ADividend YieldN/APrice Target$6.50Consensus RatingHold Company OverviewSingular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Read More… Receive OMIC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address OMIC Stock News HeadlinesSingular Genomics highlights G4X milestones at AGBTFebruary 24, 2025 | markets.businessinsider.comSingular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBTFebruary 24, 2025 | markets.businessinsider.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.May 2, 2025 | Paradigm Press (Ad)Singular Genomics announces closing of acquisition by Deerfield ManagmentFebruary 22, 2025 | markets.businessinsider.comSingular Genomics Shareholders Approve Merger AgreementFebruary 22, 2025 | investing.comSingular Genomics Announces Closing of Acquisition by Deerfield ManagementFebruary 21, 2025 | globenewswire.comSingular Genomics Systems IncFebruary 20, 2025 | morningstar.comSingular genomics CEO sells shares worth $15,912February 14, 2025 | msn.comSee More Headlines OMIC Stock Analysis - Frequently Asked Questions How have OMIC shares performed this year? Singular Genomics Systems' stock was trading at $19.43 on January 1st, 2025. Since then, OMIC stock has increased by 3.0% and is now trading at $20.01. View the best growth stocks for 2025 here. How were Singular Genomics Systems' earnings last quarter? Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($6.72) EPS for the quarter, beating the consensus estimate of ($8.05) by $1.33. The firm had revenue of $0.41 million for the quarter, compared to the consensus estimate of $0.74 million. Singular Genomics Systems had a negative net margin of 3,237.89% and a negative trailing twelve-month return on equity of 57.87%. When did Singular Genomics Systems' stock split? Singular Genomics Systems shares reverse split before market open on Wednesday, June 26th 2024. The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Singular Genomics Systems IPO? Singular Genomics Systems (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. How do I buy shares of Singular Genomics Systems? Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Singular Genomics Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Singular Genomics Systems investors own include NVIDIA (NVDA), Tesla (TSLA), Albemarle (ALB), CrowdStrike (CRWD), Etsy (ETSY), Ford Motor (F) and Fluence Energy (FLNC). Company Calendar Last Earnings11/12/2024Today5/02/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:OMIC CIK1850906 Websingulargenomics.com Phone858-333-7830FaxN/AEmployees220Year FoundedN/APrice Target and Rating Average Stock Price Target$6.50 High Stock Price Target$6.50 Low Stock Price Target$6.50 Potential Upside/Downside-67.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($35.1096) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-94,820,000.00 Net Margins-3,237.89% Pretax Margin-3,237.89% Return on Equity-57.87% Return on Assets-37.90% Debt Debt-to-Equity Ratio0.04 Current Ratio7.37 Quick Ratio6.67 Sales & Book Value Annual Sales$2.91 million Price / Sales17.47 Cash FlowN/A Price / Cash FlowN/A Book Value$73.25 per share Price / Book0.27Miscellaneous Outstanding Shares2,540,000Free Float1,974,000Market Cap$50.83 million OptionableNo Data Beta1.83 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (NASDAQ:OMIC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Singular Genomics Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Singular Genomics Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.